In the buildup to the JPM 2025 conference, Lori Ellis, Head of Insights, BioSpace is speaking with Ali Pashazadeh, Treehill Partners CEO, and Miguel Forte, President of the International Society for Cell & Gene Therapy, a board member of ARM, and CEO of Kiji Therapeutics about the current malaise within investment for the life science and biopharmaceutical sectors, and what companies can do to survive.
This is episode 1 of the discussion:
https://www.biospace.com/business/previous-investment-patterns-set-to-repeat-in-2025